Hepatitis-Endocrinology & Therapeutic Drug Testing

4.10.25 - OMH issues IFB OMH01-C202576-3650454

The NYS Office of Mental Health and the Nathan Kline Institute are seeking to procure, through an Invitation for Bid (IFB), all diagnostic test kits required for Serology and Therapeutic Drug of Abuse testing on a reagent-rental basis. In exchange for the lab purchasing these test kits, the vendor will provide ALL other materials required for testing.

For quality control purposes, the laboratory operates five days per week one shift (excludes State Holidays). Calibrations are required minimally once per month. In addition to providing and maintaining the analyzers, the vendor will be responsible for all consumables, disposables, instrument parts, and any other items directly required for the testing.

The Program Work Plan with Materials, Mandatory Specifications, etc. is located in Appendix D of the Contract Boilerplate. Interested Vendors should review the Contract Boilerplate and IFB document for further information. Included with these documents is a Bid Quote Sheet in Excel format that should be used to submit your bid.

There is an Optional site visit scheduled for Tuesday, May 13, 2025 at 1p ET.

Questions from bidders are to be submitted by Thursday, May 22 by 3p ET per the instructions in the IFB. Questions and Answers will be sent to all bidders, as well as posted to this ad, by Thursday, May 29.

Bids are due no later than 3p ET on Thursday, June 12, 2025.

Please check the Contract Reporter website frequently for updates. Any documentation regarding this procurement will be posted. Vendors are also to encouraged to check this site frequently for additional bidding opportunities.

There are no Minority and Women Business Enterprises MWBE Participation Goals for this contract.

There are no Service Disabled Veteran Owned Businesses (SVDOB) Participation Goals for this contract.

“Pursuant to the New York State Finance Law Sections 139-j and 139-k, the Procurement Lobbying Act applies to this solicitation. Only the designated, sole point of contact listed below should be contacted during the restricted period of communication. The restricted period began with the publication of this ad and will end with the formal approval by OSC of the contractual agreement”